Evidence map›Paper›PMID 36747232›Full record

ArticleTrials2023

Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials.

Ciara Buckley, Shaun Treweek, Lynn Laidlaw, Frances Shiely

Abstract readLetter
In one paragraph

Article in Trials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ciara BuckleyTrials Research and Methodologies Unit, HRB Clinical Research Facility, University College Cork, Cork, Ireland.
Shaun TreweekHealth Services Research Unit, University of Aberdeen, Aberdeen, UK.
Lynn LaidlawPatient and Public Contributor, Health Service Research Unit, Aberdeen, UK.
Frances ShielyTrials Research and Methodologies Unit, HRB Clinical Research Facility, University College Cork, Cork, Ireland. f.shiely@ucc.ie.ORCID http://orcid.org/0000-0003-0969-8321

Funding

Chief Scientist Office HSRU1
6 · The paper itself

Abstract

We recently reported that according to patients and healthcare professionals in breast cancer and nephrology trials, teams conducting the trials got their choice of primary outcome wrong (72% of the time) more often than they got it right (28% of the time). A Patient and Public Involvement (PPI) representative, co-author of this letter, asked (on Twitter) whether PPI contributors had been involved in the design of the original trials and by extension the outcome selection. The purpose of this study was to answer this question.

Indexed as

Breast NeoplasmsNephrologyFemaleHealth PersonnelHumansPatient ParticipationClinical trialsOutcomesPatient and public involvement/PPITrial methodology

Identifiers

PMID36747232
PMCPMC9903556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.